Laura E. Nagy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura E. Nagy has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Megan R. McMullen
Center for Liver Disease Research Department of Pathobiology Lerner Research Institute, Cleveland Clinic Cleveland Ohio
9 shared publications- Michele T. Pritchard
Dept. of Pharmacology, Toxicology and Therapeutics, The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS
6 shared publications Varsha Thakur
Department of Nutrition, Case Western Reserve University, Cleveland, Ohio 44106-4906, USA
4 shared publicationsRaj Kishore
Department of Nutrition, Case Western Reserve University, Cleveland, Ohio 44106-4906
3 shared publicationsSanjoy Roychowdhury
Cleveland Clin, Cleveland, OH 44106 USA
3 shared publicationsDian J. Chiang
Department of Gastroenterology and Hepatology Cleveland Clinic Cleveland Ohio
2 shared publications
Latest Publications
- Open Access
- 18 March 2020
- Published by MDPI AG in Biomedicines
- Vol. 8 (3) , 63
Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research
The following review article presents clinical and experimental features of alcohol-induced liver disease (ALD). Basic aspects of alcohol metabolism leading to the development of liver hepatotoxicity are discussed. ALD includes fatty liver, acute alcoholic hepatitis with or without liver failure, alcoholic steatohepatitis (ASH) leading to fibrosis and cirrhosis, and hepatocellular cancer (HCC). ALD is fully attributable to alcohol consumption. However, only 10–20% of heavy drinkers (persons consuming more than 40 g of ethanol/day) develop clinical ALD. Moreover, there is a link between behaviour and environmental factors that determine the amount of alcohol misuse and their liver disease. The range of clinical presentation varies from reversible alcoholic hepatic steatosis to cirrhosis, hepatic failure, and hepatocellular carcinoma. We aimed to (1) describe the clinico-pathology of ALD, (2) examine the role of immune responses in the development of alcoholic hepatitis (ASH), (3) propose diagnostic markers of ASH, (4) analyze the experimental models of ALD, (5) study the role of alcohol in changing the microbiota, and (6) articulate how findings in the liver and/or intestine influence the brain (and/or vice versa) on ASH; (7) identify pathways in alcohol-induced organ damage and (8) to target new innovative experimental concepts modeling the experimental approaches. The present review includes evidence recognizing the key toxic role of alcohol in ALD severity. Cytochrome p450 CYP2E1 activation may change the severity of ASH. The microbiota is a key element in immune responses, being an inducer of proinflammatory T helper 17 cells and regulatory T cells in the intestine. Alcohol consumption changes the intestinal microbiota and influences liver steatosis and liver inflammation. Knowing how to exploit the microbiome to modulate the immune system might lead to a new form of personalized medicine in ALF and ASH.
- 18 March 2020
- Published by MDPI AG in Biomedicines
- Vol. 8 (3) , 63
Open AccessAlcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research
The following review article presents clinical and experimental features of alcohol-induced liver disease (ALD). Basic aspects of alcohol metabolism leading to the development of liver hepatotoxicity are discussed. ALD includes fatty liver, acute alcoholic hepatitis with or without liver failure, alcoholic steatohepatitis (ASH) leading to fibrosis and cirrhosis, and hepatocellular cancer (HCC). ALD is fully attributable to alcohol consumption. However, only 10–20% of heavy drinkers (persons consuming more than 40 g of ethanol/day) develop clinical ALD. Moreover, there is a link between behaviour and environmental factors that determine the amount of alcohol misuse and their liver disease. The range of clinical presentation varies from reversible alcoholic hepatic steatosis to cirrhosis, hepatic failure, and hepatocellular carcinoma. We aimed to (1) describe the clinico-pathology of ALD, (2) examine the role of immune responses in the development of alcoholic hepatitis (ASH), (3) propose diagnostic markers of ASH, (4) analyze the experimental models of ALD, (5) study the role of alcohol in changing the microbiota, and (6) articulate how findings in the liver and/or intestine influence the brain (and/or vice versa) on ASH; (7) identify pathways in alcohol-induced organ damage and (8) to target new innovative experimental concepts modeling the experimental approaches. The present review includes evidence recognizing the key toxic role of alcohol in ALD severity. Cytochrome p450 CYP2E1 activation may change the severity of ASH. The microbiota is a key element in immune responses, being an inducer of proinflammatory T helper 17 cells and regulatory T cells in the intestine. Alcohol consumption changes the intestinal microbiota and influences liver steatosis and liver inflammation. Knowing how to exploit the microbiome to modulate the immune system might lead to a new form of personalized medicine in ALF and ASH.
- 1 April 2019
- Published by Elsevier in Journal of Hepatology
- Vol. 70 (1) , e107-e108
PS-173-Differential contribution of RIP3-mediated cell death in alcohol and non-alcohol related liver disease
- 1 April 2019
- Published by Elsevier in Journal of Hepatology
- Vol. 70 (1) , e107-e108
PS-173-Differential contribution of RIP3-mediated cell death in alcohol and non-alcohol related liver disease
- 1 April 2018
- Published by Elsevier in Journal of Hepatology
- Vol. 68, S809-S810
Delineating complement activation molecular patterns in patients with alcoholic hepatitis
- 1 April 2018
- Published by Elsevier in Journal of Hepatology
- Vol. 68, S809-S810
Delineating complement activation molecular patterns in patients with alcoholic hepatitis
- Open Access
- 24 July 2014
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 2 (5) , e00061
Moderate, chronic ethanol feeding exacerbates carbon tetrachloride–induced hepatic fibrosis via hepatocyte‐specific hypoxia‐inducible factor 1α
The hypoxia‐sensing transcriptional factor HIF1α is implicated in a variety of hepato‐pathological conditions; however, the contribution of hepatocyte‐derived HIF1α during progression of alcoholic liver injury is still controversial. HIF1α induces a variety of genes including those involved in apoptosis via p53 activation. Increased hepatocyte apoptosis is critical for progression of liver inflammation, stellate cell activation, and fibrosis. Using hepatocyte‐specific HIF1α‐deficient mice (ΔHepHIF1α−/−), here we investigated the contribution of HIF1α to ethanol‐induced hepatocyte apoptosis and its role in amplification of fibrosis after carbon tetrachloride (CCl4) exposure. Moderate ethanol feeding (11% of kcal) induced accumulation of hypoxia‐sensitive pimonidazole adducts and HIF1α expression in the liver within 4 days of ethanol feeding. Chronic CCl4 treatment increased M30‐positive cells, a marker of hepatocyte apoptosis in pair‐fed control mice. Concomitant ethanol feeding (11% of kcal) amplified CCl4‐induced hepatocyte apoptosis in livers of wild‐type mice, associated with elevated p53K386 acetylation, PUMA expression, and Ly6c+ cell infiltration. Subsequent to increased apoptosis, ethanol‐enhanced induction of profibrotic markers, including stellate cell activation, collagen 1 expression, and extracellular matrix deposition following CCl4 exposure. Ethanol‐induced exacerbation of hepatocyte apoptosis, p53K386 acetylation, and PUMA expression following CCl4 exposure was attenuated in livers of ΔHepHIF1α−/− mice. This protection was also associated with a reduction in Ly6c+ cell infiltration and decreased fibrosis in livers of ΔHepHIF1α−/− mice. In summary, these results indicate that moderate ethanol exposure leads to hypoxia/HIF1α‐mediated signaling in hepatocytes and induction of p53‐dependent apoptosis of hepatocytes, resulting in increased hepatic fibrosis during chronic CCl4 exposure.
- 24 July 2014
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 2 (5) , e00061
Open AccessModerate, chronic ethanol feeding exacerbates carbon tetrachloride–induced hepatic fibrosis via hepatocyte‐specific hypoxia‐inducible factor 1α
The hypoxia‐sensing transcriptional factor HIF1α is implicated in a variety of hepato‐pathological conditions; however, the contribution of hepatocyte‐derived HIF1α during progression of alcoholic liver injury is still controversial. HIF1α induces a variety of genes including those involved in apoptosis via p53 activation. Increased hepatocyte apoptosis is critical for progression of liver inflammation, stellate cell activation, and fibrosis. Using hepatocyte‐specific HIF1α‐deficient mice (ΔHepHIF1α−/−), here we investigated the contribution of HIF1α to ethanol‐induced hepatocyte apoptosis and its role in amplification of fibrosis after carbon tetrachloride (CCl4) exposure. Moderate ethanol feeding (11% of kcal) induced accumulation of hypoxia‐sensitive pimonidazole adducts and HIF1α expression in the liver within 4 days of ethanol feeding. Chronic CCl4 treatment increased M30‐positive cells, a marker of hepatocyte apoptosis in pair‐fed control mice. Concomitant ethanol feeding (11% of kcal) amplified CCl4‐induced hepatocyte apoptosis in livers of wild‐type mice, associated with elevated p53K386 acetylation, PUMA expression, and Ly6c+ cell infiltration. Subsequent to increased apoptosis, ethanol‐enhanced induction of profibrotic markers, including stellate cell activation, collagen 1 expression, and extracellular matrix deposition following CCl4 exposure. Ethanol‐induced exacerbation of hepatocyte apoptosis, p53K386 acetylation, and PUMA expression following CCl4 exposure was attenuated in livers of ΔHepHIF1α−/− mice. This protection was also associated with a reduction in Ly6c+ cell infiltration and decreased fibrosis in livers of ΔHepHIF1α−/− mice. In summary, these results indicate that moderate ethanol exposure leads to hypoxia/HIF1α‐mediated signaling in hepatocytes and induction of p53‐dependent apoptosis of hepatocytes, resulting in increased hepatic fibrosis during chronic CCl4 exposure.
- 30 May 2014
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 38 (6) , 1489-1501
Tributyrin Supplementation Protects Mice from Acute Ethanol-Induced Gut Injury
Background Excessive alcohol consumption leads to liver disease. Interorgan crosstalk contributes to ethanol (EtOH)‐induced liver injury. EtOH exposure causes gut dysbiosis resulting in negative alterations in intestinal fermentation byproducts, particularly decreased luminal butyrate concentrations. Therefore, in the present work, we investigated the effect of butyrate supplementation, in the form of trybutyrin, as a prophylactic treatment against EtOH‐induced gut injury. Methods C57BL/6J mice were treated with 3 different EtOH feeding protocols: chronic feeding (25 days, 32% of kcal), short‐term (2 days, 32%), or acute single gavage (5 g/kg). Tributyrin (0.83 to 10 mM) was supplemented either into the liquid diet or by oral gavage. Intestinal expression of tight junction (TJ) proteins and a butyrate receptor and transporter were evaluated, as well as liver enzymes and inflammatory markers. Results All 3 EtOH exposure protocols reduced the expression and co‐localization of TJ proteins (ZO‐1, occludin) and the expression of a butyrate receptor (GPR109A) and transporter (SLC5A8) in the ileum and proximal colon. Importantly, tributyrin supplementation protected against these effects. Protection of the intestine with tributyrin supplementation was accompanied by mitigation of EtOH‐induced increases in aspartate aminotransferase and inflammatory measures in the short‐term and acute EtOH exposure protocols, but not after chronic EtOH feeding. Conclusions These findings suggest that tributyrin supplementation could serve as a prophylactic treatment against gut injury caused by short‐term EtOH exposure.
- 30 May 2014
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 38 (6) , 1489-1501
Tributyrin Supplementation Protects Mice from Acute Ethanol-Induced Gut Injury
Background Excessive alcohol consumption leads to liver disease. Interorgan crosstalk contributes to ethanol (EtOH)‐induced liver injury. EtOH exposure causes gut dysbiosis resulting in negative alterations in intestinal fermentation byproducts, particularly decreased luminal butyrate concentrations. Therefore, in the present work, we investigated the effect of butyrate supplementation, in the form of trybutyrin, as a prophylactic treatment against EtOH‐induced gut injury. Methods C57BL/6J mice were treated with 3 different EtOH feeding protocols: chronic feeding (25 days, 32% of kcal), short‐term (2 days, 32%), or acute single gavage (5 g/kg). Tributyrin (0.83 to 10 mM) was supplemented either into the liquid diet or by oral gavage. Intestinal expression of tight junction (TJ) proteins and a butyrate receptor and transporter were evaluated, as well as liver enzymes and inflammatory markers. Results All 3 EtOH exposure protocols reduced the expression and co‐localization of TJ proteins (ZO‐1, occludin) and the expression of a butyrate receptor (GPR109A) and transporter (SLC5A8) in the ileum and proximal colon. Importantly, tributyrin supplementation protected against these effects. Protection of the intestine with tributyrin supplementation was accompanied by mitigation of EtOH‐induced increases in aspartate aminotransferase and inflammatory measures in the short‐term and acute EtOH exposure protocols, but not after chronic EtOH feeding. Conclusions These findings suggest that tributyrin supplementation could serve as a prophylactic treatment against gut injury caused by short‐term EtOH exposure.
- Top Cited Papers
- 1 April 2013
- Published by Wiley
- Vol. 3 (2) , 785-797
Kupffer Cells in the Liver
Kupffer cells are a critical component of the mononuclear phagocytic system and are central to both the hepatic and systemic response to pathogens. Kupffer cells are reemerging as critical mediators of both liver injury and repair. Kupffer cells exhibit a tremendous plasticity; depending on the local metabolic and immune environment, then can express a range of polarized phenotypes, from the proinflammatory M1 phenotype to the alternative/M2 phenotype. Multiple M2 phenotypes can be distinguished, each involved in the resolution of inflammation and wound healing. Here, we have provided an update on recent research that has contributed to the developing delineation of the contribution of Kupffer cells to different types of liver injury, with an emphasis on alcoholic and nonalcoholic liver diseases. These recent advances in our understanding of Kupffer cell function and regulation will likely provide new insights into the potential for therapeutic manipulation of Kupffer cells to promote the resolution of inflammation and enhance wound healing in liver disease. © 2013 American Physiological Society.Compr Physiol3:785‐797, 2013.
- 1 April 2013
- Published by Wiley
- Vol. 3 (2) , 785-797
Top Cited PapersKupffer Cells in the Liver
Kupffer cells are a critical component of the mononuclear phagocytic system and are central to both the hepatic and systemic response to pathogens. Kupffer cells are reemerging as critical mediators of both liver injury and repair. Kupffer cells exhibit a tremendous plasticity; depending on the local metabolic and immune environment, then can express a range of polarized phenotypes, from the proinflammatory M1 phenotype to the alternative/M2 phenotype. Multiple M2 phenotypes can be distinguished, each involved in the resolution of inflammation and wound healing. Here, we have provided an update on recent research that has contributed to the developing delineation of the contribution of Kupffer cells to different types of liver injury, with an emphasis on alcoholic and nonalcoholic liver diseases. These recent advances in our understanding of Kupffer cell function and regulation will likely provide new insights into the potential for therapeutic manipulation of Kupffer cells to promote the resolution of inflammation and enhance wound healing in liver disease. © 2013 American Physiological Society.Compr Physiol3:785‐797, 2013.
- 24 January 2012
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 36 (7) , 1139-1147
Inhibition of Apoptosis Protects Mice from Ethanol‐Mediated Acceleration of Early Markers of CC l 4 ‐Induced Fibrosis but not Steatosis or Inflammation
Background: Correlative evidence indicates that apoptosis is associated with the progression of alcoholic liver disease. If apoptosis contributes to ethanol ( EtOH )‐induced steatohepatitis and/or fibrosis, then mice deficient in B id, a key pro‐apoptotic B cl‐2 family member, or mice treated with a pan‐caspase inhibitor ( VX 166) should be resistant to EtOH ‐induced liver injury. Methods: This hypothesis was tested in mice using a model of chronic, heavy EtOH ‐induced liver injury, as well as in a model in which moderate EtOH feeding accelerated the appearance of early markers of hepatic fibrosis in response to acute carbon tetrachloride (CCl 4 ) exposure. Results: Chronic EtOH feeding to mice increased TUNEL ‐ and cytokeratin‐18‐positive cells in the liver, as well as the expression of receptor‐interacting protein kinase 3 ( RIP 3), a marker of necroptosis. In this model, B id−/− mice or wild‐type mice treated with VX 166 were protected from EtOH ‐induced apoptosis, but not EtOH ‐induced RIP 3 expression. Bid deficiency or inhibition of caspase activity did not protect mice from EtOH ‐induced increases in plasma alanine and aspartate amino transferase activity, steatosis, or mRNA expression of some inflammatory cytokines. Moderate EtOH feeding to mice enhanced the response of mice to acute CCl 4 exposure, resulting in increased expression of α‐smooth muscle actin and accumulation of extracellular matrix protein. VX 166‐treatment attenuated EtOH ‐mediated acceleration of these early indicators of CCl 4 ‐induced hepatic fibrosis, decreasing the expression of α‐smooth muscle actin, and the accumulation of extracellular matrix protein. Conclusions: EtOH‐induced apoptosis of hepatocytes was mediated by B id. Apoptosis played a critical role in the accelerating the appearance of early markers of CCl 4 ‐induced fibrosis by moderate EtOH but did not contribute to EtOH ‐induced hepatocyte injury, steatosis, or expression of mRNA for some inflammatory cytokines.
- 24 January 2012
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 36 (7) , 1139-1147
Inhibition of Apoptosis Protects Mice from Ethanol‐Mediated Acceleration of Early Markers of CC l 4 ‐Induced Fibrosis but not Steatosis or Inflammation
Background: Correlative evidence indicates that apoptosis is associated with the progression of alcoholic liver disease. If apoptosis contributes to ethanol ( EtOH )‐induced steatohepatitis and/or fibrosis, then mice deficient in B id, a key pro‐apoptotic B cl‐2 family member, or mice treated with a pan‐caspase inhibitor ( VX 166) should be resistant to EtOH ‐induced liver injury. Methods: This hypothesis was tested in mice using a model of chronic, heavy EtOH ‐induced liver injury, as well as in a model in which moderate EtOH feeding accelerated the appearance of early markers of hepatic fibrosis in response to acute carbon tetrachloride (CCl 4 ) exposure. Results: Chronic EtOH feeding to mice increased TUNEL ‐ and cytokeratin‐18‐positive cells in the liver, as well as the expression of receptor‐interacting protein kinase 3 ( RIP 3), a marker of necroptosis. In this model, B id−/− mice or wild‐type mice treated with VX 166 were protected from EtOH ‐induced apoptosis, but not EtOH ‐induced RIP 3 expression. Bid deficiency or inhibition of caspase activity did not protect mice from EtOH ‐induced increases in plasma alanine and aspartate amino transferase activity, steatosis, or mRNA expression of some inflammatory cytokines. Moderate EtOH feeding to mice enhanced the response of mice to acute CCl 4 exposure, resulting in increased expression of α‐smooth muscle actin and accumulation of extracellular matrix protein. VX 166‐treatment attenuated EtOH ‐mediated acceleration of these early indicators of CCl 4 ‐induced hepatic fibrosis, decreasing the expression of α‐smooth muscle actin, and the accumulation of extracellular matrix protein. Conclusions: EtOH‐induced apoptosis of hepatocytes was mediated by B id. Apoptosis played a critical role in the accelerating the appearance of early markers of CCl 4 ‐induced fibrosis by moderate EtOH but did not contribute to EtOH ‐induced hepatocyte injury, steatosis, or expression of mRNA for some inflammatory cytokines.
- 6 September 2011
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 36 (2) , 214-222
Ethanol‐Induced Oxidative Stress via the CYP2E1 Pathway Disrupts Adiponectin Secretion from Adipocytes
Background: Adipose tissue is an important target for ethanol action. One important effect of ethanol is to reduce the secretion of adiponectin from adipocytes; this decrease is associated with lowered circulating adiponectin in rodent models of chronic ethanol feeding. Adiponectin is an insulin‐sensitizing, anti‐inflammatory adipokine; decreased adiponectin activity may contribute to tissue injury in response to chronic ethanol. Here, we investigated the role of cytochrome P450 2E1 (CYP2E1) and oxidative stress in the mechanism for impaired adiponectin secretion from adipocytes in response to ethanol. Methods: Male Wistar rats were fed a liquid diet containing ethanol as 36% of calories or pair‐fed a control diet for 4 weeks. 3T3‐L1 adipocyte cultures, expressing CYP2E1 or not, were exposed to ethanol or 4‐hydroxynonenal (4‐HNE). Results: Chronic ethanol feeding to rats suppressed the secretion of adiponectin from isolated epididymal adipocytes. Ethanol feeding induced the expression of CYP2E1 in adipocytes and increased markers of oxidative stress, including 4‐HNE and protein carbonyls. Because adiponectin is posttranslationally processed in the endoplasmic reticulum and Golgi, we investigated the impact of ethanol on the redox status of high‐density microsomes. Chronic ethanol decreased the ratio of reduced glutathione to oxidized glutathione (4.6:1, pair‐fed; 2.9:1, ethanol‐fed) in high‐density microsomes isolated from rat epididymal adipose tissue. We next utilized the 3T3‐L1 adipocyte‐like cell model to interrogate the mechanisms for impaired adiponectin secretion. Culture of 3T3‐L1 adipocytes overexpressing exogenous CYP2E1, but not those overexpressing antisense CYP2E1, with ethanol increased oxidative stress and impaired adiponectin secretion from intracellular pools. Consistent with a role of oxidative stress in impaired adiponectin secretion, challenge of 3T3‐L1 adipocytes with 4‐HNE also reduced adiponectin mRNA expression and secretion, without affecting intracellular adiponectin concentration. Conclusions: These data demonstrate that CYP2E1‐dependent reactive oxygen species production in response to ethanol disrupts adiponectin secretion from adipocytes.
- 6 September 2011
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 36 (2) , 214-222
Ethanol‐Induced Oxidative Stress via the CYP2E1 Pathway Disrupts Adiponectin Secretion from Adipocytes
Background: Adipose tissue is an important target for ethanol action. One important effect of ethanol is to reduce the secretion of adiponectin from adipocytes; this decrease is associated with lowered circulating adiponectin in rodent models of chronic ethanol feeding. Adiponectin is an insulin‐sensitizing, anti‐inflammatory adipokine; decreased adiponectin activity may contribute to tissue injury in response to chronic ethanol. Here, we investigated the role of cytochrome P450 2E1 (CYP2E1) and oxidative stress in the mechanism for impaired adiponectin secretion from adipocytes in response to ethanol. Methods: Male Wistar rats were fed a liquid diet containing ethanol as 36% of calories or pair‐fed a control diet for 4 weeks. 3T3‐L1 adipocyte cultures, expressing CYP2E1 or not, were exposed to ethanol or 4‐hydroxynonenal (4‐HNE). Results: Chronic ethanol feeding to rats suppressed the secretion of adiponectin from isolated epididymal adipocytes. Ethanol feeding induced the expression of CYP2E1 in adipocytes and increased markers of oxidative stress, including 4‐HNE and protein carbonyls. Because adiponectin is posttranslationally processed in the endoplasmic reticulum and Golgi, we investigated the impact of ethanol on the redox status of high‐density microsomes. Chronic ethanol decreased the ratio of reduced glutathione to oxidized glutathione (4.6:1, pair‐fed; 2.9:1, ethanol‐fed) in high‐density microsomes isolated from rat epididymal adipose tissue. We next utilized the 3T3‐L1 adipocyte‐like cell model to interrogate the mechanisms for impaired adiponectin secretion. Culture of 3T3‐L1 adipocytes overexpressing exogenous CYP2E1, but not those overexpressing antisense CYP2E1, with ethanol increased oxidative stress and impaired adiponectin secretion from intracellular pools. Consistent with a role of oxidative stress in impaired adiponectin secretion, challenge of 3T3‐L1 adipocytes with 4‐HNE also reduced adiponectin mRNA expression and secretion, without affecting intracellular adiponectin concentration. Conclusions: These data demonstrate that CYP2E1‐dependent reactive oxygen species production in response to ethanol disrupts adiponectin secretion from adipocytes.
- Open Access
- 15 October 2010
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (8) , 4928-4937
Adiponectin and Heme Oxygenase-1 Suppress TLR4/MyD88-Independent Signaling in Rat Kupffer Cells and in Mice after Chronic Ethanol Exposure
Alcoholic liver disease is mediated via activation of TLR4 signaling; MyD88-dependent and -independent signals are important contributors to injury in mouse models. Adiponectin, an anti-inflammatory adipokine, suppresses TLR4/MyD88-dependent responses via induction of heme oxygenase-1 (HO-1). Here we investigated the interactions between chronic ethanol, adiponectin, and HO-1 in regulation of TLR4/MyD88-independent signaling in macrophages and an in vivo mouse model. After chronic ethanol feeding, LPS-stimulated expression of IFN-β and CXCL10 mRNA was increased in primary cultures of Kupffer cells compared with pair-fed control mice. Treatment of Kupffer cells with globular adiponectin (gAcrp) normalized this response. LPS-stimulated IFN-β/CXCL10 mRNA and CXCL10 protein was also reduced in RAW 264.7 macrophages treated with gAcrp or full-length adiponectin. gAcrp and full-length adiponectin acted via adiponectin receptors 1 and 2, respectively. gAcrp decreased TLR4 expression in both Kupffer cells and RAW 264.7 macrophages. Small interfering RNA knockdown of HO-1 or inhibition of HO-1 activity with zinc protoporphyrin blocked these effects of gAcrp. C57BL/6 mice were exposed to chronic ethanol feeding, with or without treatment with cobalt protoporphyrin, to induce HO-1. After chronic ethanol feeding, mice were sensitized to in vivo challenge with LPS, expressing increased IFN-β/CXCL10 mRNA and CXCL10 protein in liver compared with control mice. Pretreatment with cobalt protoporphyrin 24 h before LPS challenge normalized this effect of ethanol. Adiponectin and induction of HO-1 potently suppressed TLR4-dependent/MyD88-independent cytokine expression in primary Kupffer cells from rats and in mouse liver after chronic ethanol exposure. These data suggest that induction of HO-1 may be a useful therapeutic strategy in alcoholic liver disease.
- 15 October 2010
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (8) , 4928-4937
Open AccessAdiponectin and Heme Oxygenase-1 Suppress TLR4/MyD88-Independent Signaling in Rat Kupffer Cells and in Mice after Chronic Ethanol Exposure
Alcoholic liver disease is mediated via activation of TLR4 signaling; MyD88-dependent and -independent signals are important contributors to injury in mouse models. Adiponectin, an anti-inflammatory adipokine, suppresses TLR4/MyD88-dependent responses via induction of heme oxygenase-1 (HO-1). Here we investigated the interactions between chronic ethanol, adiponectin, and HO-1 in regulation of TLR4/MyD88-independent signaling in macrophages and an in vivo mouse model. After chronic ethanol feeding, LPS-stimulated expression of IFN-β and CXCL10 mRNA was increased in primary cultures of Kupffer cells compared with pair-fed control mice. Treatment of Kupffer cells with globular adiponectin (gAcrp) normalized this response. LPS-stimulated IFN-β/CXCL10 mRNA and CXCL10 protein was also reduced in RAW 264.7 macrophages treated with gAcrp or full-length adiponectin. gAcrp and full-length adiponectin acted via adiponectin receptors 1 and 2, respectively. gAcrp decreased TLR4 expression in both Kupffer cells and RAW 264.7 macrophages. Small interfering RNA knockdown of HO-1 or inhibition of HO-1 activity with zinc protoporphyrin blocked these effects of gAcrp. C57BL/6 mice were exposed to chronic ethanol feeding, with or without treatment with cobalt protoporphyrin, to induce HO-1. After chronic ethanol feeding, mice were sensitized to in vivo challenge with LPS, expressing increased IFN-β/CXCL10 mRNA and CXCL10 protein in liver compared with control mice. Pretreatment with cobalt protoporphyrin 24 h before LPS challenge normalized this effect of ethanol. Adiponectin and induction of HO-1 potently suppressed TLR4-dependent/MyD88-independent cytokine expression in primary Kupffer cells from rats and in mouse liver after chronic ethanol exposure. These data suggest that induction of HO-1 may be a useful therapeutic strategy in alcoholic liver disease.
- 29 May 2007
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (s1) , S53-S56
Regulation of macrophage activation in alcoholic liver disease
Chronic ethanol feeding sensitizes Kupffer cells to activation by lipopolysaccharide (LPS), leading to increased production of tumor necrosis factor α (TNFα). The regulation of TNFα synthesis is controlled by both transcriptional and post‐transcriptional mechanisms via the integration of complex signal transduction pathways activated in response to LPS exposure. Recent data has shown that increased LPS‐stimulated phosphorylation of extracellular signal‐regulated kinase pathway 1/2 (ERK1/2) is one of the important molecular targets of chronic ethanol in Kupffer cells. This increased activation of ERK1/2 after chronic ethanol is associated with increased expression of Egr‐1, a transcription factor required for enhanced LPS‐stimulated TNFα mRNA expression after chronic ethanol exposure. egr‐1 null mice are protected from the development of fatty liver injury in response to chronic ethanol feeding, identifying an essential role for Egr‐1 in the development of chronic ethanol‐induced liver injury. Here we review recent studies aimed at understanding the mechanisms by which chronic ethanol enhances the LPS→ERK1/2→Egr‐1→ΤNFα pathway in Kupffer cells. These studies identify a critical role for nicotinamide adenine dinucleotide phosphate (NADPH) oxidase‐derived reactive oxygen species in the activation of ERK1/2 and subsequent production of TNFα in Kupffer cells after chronic ethanol feeding.
- 29 May 2007
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (s1) , S53-S56
Regulation of macrophage activation in alcoholic liver disease
Chronic ethanol feeding sensitizes Kupffer cells to activation by lipopolysaccharide (LPS), leading to increased production of tumor necrosis factor α (TNFα). The regulation of TNFα synthesis is controlled by both transcriptional and post‐transcriptional mechanisms via the integration of complex signal transduction pathways activated in response to LPS exposure. Recent data has shown that increased LPS‐stimulated phosphorylation of extracellular signal‐regulated kinase pathway 1/2 (ERK1/2) is one of the important molecular targets of chronic ethanol in Kupffer cells. This increased activation of ERK1/2 after chronic ethanol is associated with increased expression of Egr‐1, a transcription factor required for enhanced LPS‐stimulated TNFα mRNA expression after chronic ethanol exposure. egr‐1 null mice are protected from the development of fatty liver injury in response to chronic ethanol feeding, identifying an essential role for Egr‐1 in the development of chronic ethanol‐induced liver injury. Here we review recent studies aimed at understanding the mechanisms by which chronic ethanol enhances the LPS→ERK1/2→Egr‐1→ΤNFα pathway in Kupffer cells. These studies identify a critical role for nicotinamide adenine dinucleotide phosphate (NADPH) oxidase‐derived reactive oxygen species in the activation of ERK1/2 and subsequent production of TNFα in Kupffer cells after chronic ethanol feeding.